A phase II trial of docetaxel (taxotere) in combination with epirubicin as neoadjuvant chemotherapy in patients with locally advanced breast cancer

被引：0
|
作者：
Fried, G
Zidan, J
Epelbaum, R
Keren-Rosenberg, S
Basher, W
Steckelman, I
Kogan, F
Haim, N
机构：
[1] Poriya Govt Hosp, Tiberias, Israel
[2] Sieff Hosp, Safed, Israel
[3] Rambam Med Ctr, Haifa, Israel
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
10.1016/S0959-8049(02)80207-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [1] The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer
    Hirano, A
    Shimizu, T
    Imamura, H
    Watanabe, O
    Kinoshita, J
    Okabe, T
    Kimura, K
    Kamimura, M
    Domoto, K
    Aiba, M
    Ogawa, K
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 581 - 584
  • [2] Phase II trial of the combination docetaxel and doxorubicin as neoadjuvant chemotherapy in locally advanced or inflammatory inoperable breast cancer
    Chahine, Georges Y.
    Dagher, Joya E.
    Sleilaty, Ghassan S.
    El Karak, Fadi R.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 32 - 32
  • [3] A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer
    Yao, Xin
    Hosenpud, Janet
    Chitambar, Christopher R.
    Charlson, John
    Cheng, Yee Chung
    [J]. JOURNAL OF CANCER, 2012, 3 : 145 - 151
  • [4] A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
    Lee, Jinsun
    Kim, Jeryong
    Chang, Eilsung
    Choi, Woonjung
    Lee, Kwangman
    Yoon, Hyunjo
    Jung, Sunghoo
    Park, Minho
    Yoon, Junghan
    Kim, Sungyong
    [J]. JOURNAL OF BREAST CANCER, 2014, 17 (04) : 344 - 349
  • [5] A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer
    Yardley, Denise A.
    Peacock, Nancy W.
    Dickson, Natalie R.
    White, Melissa B.
    Vazquez, Elizabeth R.
    Foust, John T.
    Grapski, Richard
    Hendricks, Linda K.
    Scott, William L.
    Hainsworth, John D.
    [J]. CLINICAL BREAST CANCER, 2010, 10 (03) : 217 - 223
  • [6] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, D.
    Scalone, S.
    Crivellari, D.
    La Mura, N.
    Miolo, G.
    Murrone, A.
    Perin, T.
    Coran, F.
    Candiani, E.
    Massarut, S.
    Veronesi, A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [7] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, Davide
    Scalone, Simona
    Crivellari, Diana
    Magri, Maria Donatella
    La Mura, Nicoletta
    Miolo, GianMaria
    Murrone, Antonio
    Perin, Tiziana
    Coran, Francesco
    Candiani, Ezio
    Massarut, Samuele
    Veronesi, Andrea
    [J]. TUMORI JOURNAL, 2010, 96 (02): : 229 - 233
  • [8] A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
    Jeon, Ye Won
    Kim, Tae Hyun
    Youn, Hyun Jo
    Han, Sehwan
    Jung, Yongsik
    Gwak, Geumhee
    Park, Young Sam
    Kim, Jeong Soo
    Suh, Young Jin
    [J]. JOURNAL OF BREAST CANCER, 2017, 20 (04) : 340 - 346
  • [9] Combination of vinorelbine, epirubicin, and cyclophosphamide as Neoadjuvant chemotherapy for locally advanced breast cancer - Phase II study
    Braud, AC
    Levy, E
    Feuilhade, F
    Otmezguine, Y
    Calitchi, E
    Kirova, Y
    Le Bourgeois, JP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (03): : 303 - 307
  • [10] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
12345